Highly expressed in normal hematopoietic stem cells, METTL14 impeded myeloid differentiation and showed oncogenic function via m6A modification of its target mRNA in acute myeloid leukemia [23]. This evidence concerns the gene METTL14 and acute myeloid leukemia.